Emergent BioSolutions IncAdd to My Watchlist

EBS:USNew YorkIndustry: Medical-Biomedical/Gene
  • 40.05
  • 0.53  -1.31%
    Today's Change
  • 40.58
    Previous Close
  • Today
    52 Week Low - High
5:05 pm ET 10/23/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding41 million
Market Cap$2 billion
Return on Equity ttm10.63%
Last DividendEBS:US does not pay a dividend
EPS: Year Actual ttm1.664
EPS: Year Est. 12/17 ttm1.525
EPS: Quarterly Actual 6/17 0.13
EPS: Quarterly Est. 9/17 0.42
Price/Earnings ttm24.08
Relative Price/Earnings1.099
Earnings Growth Rate-34.18
Company Description
Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company. The Company develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. Emergent also develops and commercializes therapeutics and other specialty products for hospitals and clinics.
Revenue$489 million
Net Income$45 million
Total Assets$970 million
Web Sitewww.emergentbiosolutions.com

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!